Showing results (1-10 of 131) with videos related to
Sort By:
Pageof 14
Ecancermedicalscience|July 24, 2018
Propranolol and breast cancer-a work in progressPan Pantziarka, Brad A Bryan, Sergio Crispino, et al.Veterinary Sciences|October 25, 2017
Beta Adrenergic Signaling: A Targetable Regulator of Angiosarcoma and HemangiosarcomaErin B Dickerson, Brad A BryanEcancermedicalscience|February 20, 2018
Does the oncology community have a rejection bias when it comes to repurposed drugs?Bishal Gyawali, Pan Pantziarka, Sergio Crispino, et al.Ecancermedicalscience|July 31, 2020
Repurposing of drugs for triple negative breast cancer: an overviewAndrea Spini, Sandra Donnini, Pan Pantziarka, et al.Ecancermedicalscience|May 11, 2018
Repurposing drugs in oncology (ReDO)-selective PDE5 inhibitors as anti-cancer agentsPan Pantziarka, Vidula Sukhatme, Sergio Crispino, et al.JAMA Dermatology|September 17, 2015
Growth Attenuation of Cutaneous Angiosarcoma With Propranolol-Mediated β-BlockadeWilliam Chow, Clarissa N Amaya, Steven Rains, et al.Ecancermedicalscience|June 18, 2015
Primed for cancer: Li Fraumeni Syndrome and the pre-cancerous nichePan PantziarkaCancer Cell International|April 17, 2013
Li Fraumeni syndrome, cancer and senescence: a new hypothesisPan PantziarkaCancers|April 12, 2022
Inhibiting the Priming for Cancer in Li-Fraumeni SyndromePan Pantziarka, Sarah BlagdenPageof 14